Skip to content

Cognitive Control Training for Remitted Depressed Patients

Cognitive Control Training as a Preventive Intervention for Depression: A Double-blind Randomized Controlled Trial Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02407652
Enrollment
68
Registered
2015-04-03
Start date
2014-12-31
Completion date
2015-10-31
Last updated
2015-12-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Major Depression in Remission

Brief summary

The purpose of this study is to explore the effectiveness of an internet-delivered cognitive control training as a preventive intervention for remitted depressed patients.

Detailed description

Prospective studies have linked impaired cognitive control to increased cognitive vulnerability for future depression. Importantly, experimental studies indicate that cognitive control training can be used to reduce rumination and depressive symptomatology in MDD samples. Furthermore, studies exploring the potential of cognitive control training in at-risk undergraduate students indicate that cognitive control training has beneficial effects on rumination, an important vulnerability factor for depression. Provided that remitted depressed patients form a high-risk group for developing future depressive episodes, the current study will explore whether internet-delivered cognitive control training can be used to reduce vulnerability for future depression in remitted depressed patients. The investigators will explore effects on depressive symptomatology, (mal-)adaptive emotion regulation (directly following training and at 3 months follow-up), and indices of functioning (at 3 months follow-up).

Interventions

10 adaptive Paced Auditory Serial Addition Task (PASAT) sessions, 400 trials each

BEHAVIORALLow Cognitive Load Training

10 low cognitive load sessions, 400 trials each

Sponsors

University Ghent
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
23 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* History of ≥ 1 depressive episode(s) * Currently in stable full or partial remission (≥ 6 months)

Exclusion criteria

* Major depressive disorder (MDD; current) * Bipolar disorder (current and/or previous) * Psychotic disorder (current and/or previous) * Neurological impairments (current and/or previous) * Excessive substance abuse (current and/or previous) * No other comorbid disorders (current) * No ongoing psychotherapeutic treatment (maintenance treatment is allowed, but with a frequency less than once / 3 weeks) * Use of antidepressant medication is allowed if kept at a constant level

Design outcomes

Primary

MeasureTime frameDescription
Change in depressive symptomatology from baseline to the post-training assessment and follow-up (BDI-II)baseline, 2 weeks, 3 monthsAssessed using the Beck Depression Inventory (BDI-II)
Change in depressive rumination from baseline to the post-training assessment and follow-up (RRS)baseline, 2 weeks, 3 monthsAssessed using the Ruminative Response Scale (RRS)

Secondary

MeasureTime frameDescription
Quality of Life (QLDS)baseline, 3 monthsAssessed using the Quality of Life in Depression Scale (QLDS)
Resilience (RS)baseline, 3 monthsAssessed using the Resilience Scale (RS)
Remission from depression (RDQ)baseline, 3 monthsAssessed using the Remission of Depression Questionnaire (RDQ)
Disability (WHODAS 2.0)baseline, 3 monthsAssessed using the World Health Organization Disability Assessment Schedule 2.0 (WHODAS 2.0)
(mal-)Adaptive cognitive emotion regulation (CERQ)baseline, 2 weeks, 3 monthsAssessed using the Cognitive Emotion Regulation Questionnaire (CERQ)

Other

MeasureTime frameDescription
Behavioral measure for cognitive control ((non-adaptive) PASAT)baseline, 2 weeks, 3 monthsAssessed using the (non-adaptive) PASAT
Self-reported cognitive control (BRIEF-A)baseline, 2 weeks, 3 monthsAssessed using the Behaviour Rating Inventory of Executive Function Adult Version (BRIEF-A)

Countries

Belgium

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 17, 2026